Correction: Retrospective Study on the Use of Brodalumab for Atopic Dermatitis Management: Real-World Insights - Summary - MDSpire

Correction: Retrospective Study on the Use of Brodalumab for Atopic Dermatitis Management: Real-World Insights

  • By

  • Nikolaos Stavropoulos

  • Daniel Myszkowski

  • Dennis Braß

  • Vasileios Dervenis

  • Effimia Poungoura

  • Eggert Stockfleth

  • February 6, 2026

  • 0 min

Share

Objective:

To provide insights on the use of brodalumab for managing atopic dermatitis.

Key Findings:
  • Brodalumab is the correct medication discussed for atopic dermatitis management.
Interpretation:

The correction clarifies the focus of the study on brodalumab's effectiveness in real-world settings.

Limitations:
Conclusion:

The article has been updated to accurately reflect the medication under study.

Original Source(s)

Correction: Retrospective Study on the Use of Brodalumab for Atopic Dermatitis Management: Real-World Insights

  • by Nikolaos Stavropoulos, Daniel Myszkowski, Dennis Braß, Vasileios Dervenis, Effimia Poungoura, Eggert Stockfleth

  • February 6, 2026

Related Content

Overview of Findings: Real-World Outcomes of Systemic Therapies for Moderate-to-Severe Atopic Dermatitis in Children Aged 12 and Younger from the PEDISTAD Registry

Evaluating Itch in Atopic Dermatitis: Perspectives from UK Dermatologists Through a Cross-Sectional Survey and Narrative Review

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.